May 08, 2018 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial …
Momenta Pharmaceuticals Inc. (MNTA) announced Tuesday morning that the U.S. District ... Momenta Pharmaceuticals gapped up Tuesday and rose sharply during the first 45 minutes of trade. The stock took out the session highs around …
Inc. MNTA announced that it has entered into an exclusive research collaboration and worldwide license agreement with CSL Limited. Momenta’s share price has outperformed the Zacks classified Medical Biomed/Genetics in the last twelve …
Today we are offering reports on MYL, MNTA, RIGL, and SCYX which can be accessed for free ... Pennsylvania …
WRCB1mon
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) provided a corporate update and reviewed key ... expenses (which is net of Mylan's share of collaboration expenses), excluding stock-based compensation expense and net of collaborative …
MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it has received commitments from selected investors to purchase 2.8 million shares of its common stock at a …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA Keywords: Momenta …
Momenta Pharmaceuticals, Inc. : News, information and stories for Momenta Pharmaceuticals, Inc. | Nasdaq: MNTA | …
Feb. 14, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing ... including an increase in stock-based compensation, and increased lab and facilities costs. General and …
As for individual stocks, Barnes & Noble (NYSE: BKS) fell sharply on disappointing holiday sales, and Momenta Pharmaceuticals (NASDAQ: MNTA) jumped after the company reported positive results from a drug trial. Rising stock …